Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$20.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 27 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 118 most recent Form 4 transactions.
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 78,917 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 63,133 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 63,133 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 45,970 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 45,970 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 45,970 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 61,295 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 61,295 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 29,754 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 616,040 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 526,113 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 510,789 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 495,912 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 431,228 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 385,025 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 308,020 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 433,153 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 462,030 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER◆ | 385,025 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER | 1.5M | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | — | Supernus, Inc. | JOTHER | 1.9M | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 341,610 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 331,660 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 322,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 280,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 250,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 200,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 281,250 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 300,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 250,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 204,966 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 169,147 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 19,320 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 400,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER | 958,100 | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER | 1.3M | — | — | -100.0% | Open the original filing on SEC.gov |
| Oct 30 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 400,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 12 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 29,849 | — | — | — | Open the original filing on SEC.gov |
| Aug 12 | SUPN | Supernus Pharmaceuticals,… | FTAX | 12,642 | $46.57 | $588.7K | -1.0% | Open the original filing on SEC.gov |
| Aug 12 | SUPN | Supernus Pharmaceuticals,… | MEXER | 29,849 | — | — | +2.4% | Open the original filing on SEC.gov |
| Jul 29 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 29,849 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | CGTX | Cognition Therapeutics INC | AGRANT | 25,000 | — | — | +51.5% | Open the original filing on SEC.gov |
| Mar 13 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 120 | $51.75 | $6.2K | <0.1% | Open the original filing on SEC.gov |
| Mar 13 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 10,742 | $51.00 | $547.8K | -1.1% | Open the original filing on SEC.gov |
| Mar 13 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 24,138 | $50.09 | $1.2M | -2.4% | Open the original filing on SEC.gov |
| Mar 13 | SUPN | Supernus Pharmaceuticals,… | JOTHER◷ | 12,500 | — | — | -1.2% | Open the original filing on SEC.gov |
| Mar 13 | SUPN | Supernus Pharmaceuticals,… | JOTHER◷ | 12,500 | — | — | +1.0% | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 38,640 | — | — | — | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | FTAX | 16,574 | $54.73 | $907.1K | -1.3% | Open the original filing on SEC.gov |
| Mar 6 | SUPN | Supernus Pharmaceuticals,… | MEXER | 38,640 | — | — | +3.2% | Open the original filing on SEC.gov |
| Feb 28 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 38,640 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 341,610 | — | — | — | Open the original filing on SEC.gov |
| Oct 9, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 81,250 | — | — | — | Open the original filing on SEC.gov |
| Oct 9, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 1,529 | $51.46 | $78.7K | -0.1% | Open the original filing on SEC.gov |
| Oct 9, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 58,371 | $50.55 | $3M | -4.6% | Open the original filing on SEC.gov |
| Oct 9, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 81,250 | $25.30 | $2.1M | +6.9% | Open the original filing on SEC.gov |
| Oct 7, 2025 | SCPH | scPharmaceuticals Inc. | DTOISS◆ | 6,124 | — | — | — | Open the original filing on SEC.gov |
| Oct 7, 2025 | SCPH | scPharmaceuticals Inc. | DTOISS◆ | 16,300 | — | — | — | Open the original filing on SEC.gov |
| Oct 7, 2025 | SCPH | scPharmaceuticals Inc. | DTOISS◆ | 19,750 | — | — | — | Open the original filing on SEC.gov |
| Oct 7, 2025 | SCPH | scPharmaceuticals Inc. | DTOISS◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 7, 2025 | SCPH | scPharmaceuticals Inc. | UTENDR | 5,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 19,320 | — | — | — | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | FTAX | 7,529 | $46.21 | $347.9K | -0.6% | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER | 19,320 | — | — | +1.7% | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | FTAX | 7,796 | $46.21 | $360.3K | -0.7% | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER | 20,000 | — | — | +1.7% | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 2,267 | — | — | — | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 1,904 | $48.06 | $91.5K | -0.2% | Open the original filing on SEC.gov |
| Oct 2, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 2,267 | $25.30 | $57.4K | +0.2% | Open the original filing on SEC.gov |
| Oct 1, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 53,785 | — | — | — | Open the original filing on SEC.gov |
| Oct 1, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 40,173 | $48.07 | $1.9M | -3.3% | Open the original filing on SEC.gov |
| Oct 1, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 53,785 | $25.30 | $1.4M | +4.7% | Open the original filing on SEC.gov |
| Sep 30, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 11,510 | — | — | — | Open the original filing on SEC.gov |
| Sep 30, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 8,588 | $48.25 | $414.4K | -0.7% | Open the original filing on SEC.gov |
| Sep 30, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 11,510 | $25.30 | $291.2K | +1.0% | Open the original filing on SEC.gov |
| Sep 29, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 13,688 | — | — | — | Open the original filing on SEC.gov |
| Sep 29, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 10,235 | $48.02 | $491.5K | -0.9% | Open the original filing on SEC.gov |
| Sep 29, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 13,688 | $25.30 | $346.3K | +1.2% | Open the original filing on SEC.gov |
| Sep 23, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 47,940 | — | — | — | Open the original filing on SEC.gov |
| Sep 23, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 29,513 | $47.23 | $1.4M | -2.5% | Open the original filing on SEC.gov |
| Sep 23, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 47,940 | $12.98 | $622.3K | +4.3% | Open the original filing on SEC.gov |
| Sep 22, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 27,060 | — | — | — | Open the original filing on SEC.gov |
| Sep 22, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 16,587 | $47.02 | $779.9K | -1.5% | Open the original filing on SEC.gov |
| Sep 22, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 27,060 | $12.98 | $351.2K | +2.4% | Open the original filing on SEC.gov |
| Sep 10, 2025 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 19,320 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 8, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 8,074 | — | — | — | Open the original filing on SEC.gov |
| Sep 8, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 6,322 | $46.29 | $292.6K | -0.6% | Open the original filing on SEC.gov |
| Sep 8, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 8,074 | $25.30 | $204.3K | +0.7% | Open the original filing on SEC.gov |
| Sep 5, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 73,176 | — | — | — | Open the original filing on SEC.gov |
| Sep 5, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 55,578 | $46.01 | $2.6M | -4.8% | Open the original filing on SEC.gov |
| Sep 5, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 73,176 | $25.30 | $1.9M | +6.7% | Open the original filing on SEC.gov |
| Aug 28, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 38,779 | — | — | — | Open the original filing on SEC.gov |
| Aug 28, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 24,150 | $45.12 | $1.1M | -2.2% | Open the original filing on SEC.gov |
| Aug 28, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 38,779 | $12.98 | $503.4K | +3.6% | Open the original filing on SEC.gov |
| Aug 27, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 17,195 | — | — | — | Open the original filing on SEC.gov |
| Aug 27, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 10,650 | $45.05 | $479.8K | -1.0% | Open the original filing on SEC.gov |
| Aug 27, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 17,195 | $12.98 | $223.2K | +1.6% | Open the original filing on SEC.gov |
| Aug 25, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 1,611 | — | — | — | Open the original filing on SEC.gov |
| Aug 25, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 1,000 | $45.00 | $45K | <0.1% | Open the original filing on SEC.gov |
| Aug 25, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 1,611 | $12.98 | $20.9K | +0.1% | Open the original filing on SEC.gov |
| Aug 22, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 2,415 | — | — | — | Open the original filing on SEC.gov |
| Aug 22, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 1,500 | $45.00 | $67.5K | -0.1% | Open the original filing on SEC.gov |
| Aug 22, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 2,415 | $12.98 | $31.3K | +0.2% | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 81,250 | — | — | — | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 63,500 | $43.12 | $2.7M | -5.6% | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 81,250 | $25.30 | $2.1M | +7.7% | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 38,000 | $42.00 | $1.6M | -3.5% | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 60,000 | $12.98 | $778.8K | +5.8% | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 38,500 | $40.24 | $1.5M | -3.6% | Open the original filing on SEC.gov |
| Aug 6, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◷ | 60,000 | $12.98 | $778.8K | +5.9% | Open the original filing on SEC.gov |
| Jun 18, 2025 | CGTX | Cognition Therapeutics INC | AGRANT | 34,000 | — | — | +234.5% | Open the original filing on SEC.gov |
| Jun 3, 2025 | SCPH | scPharmaceuticals Inc. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |